Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

SU‐FF‐T‐08: Tomotherapy Megavoltage Imaging for Gynecological Brachytherapy Treatment Planning and IMRT Integration

View through CrossRef
Purpose: To demonstrate the use of the Tomotherapy IMRT system to image the standard shielded Fletcher‐Suit applicator for CT based brachytherapy dose calculations and to integrate those dose distributions into Tomotherapy treatment plans. Method and Materials: A standard Fletcher‐Suit gynecological applicator was placed in phantom and a megavoltage CT scan was done using the Tomotherapy unit. The images were exported in DICOM format to a Pinnacle treatment planning system. Cesium tubes representing a typical tandem and ovoid loading of the applicator were entered into the planning system, and the dose distribution was calculated. The binary dose matrix was then converted to a CT‐like file by separating the dose values into individual planes, turning the floating point numbers into 12‐bit integers, and adding a header file. Those image files was exported to a Focal Sim viewing station, where the isodose distribution was merged with a phantom CT and contours representing different isosurfaces were drawn. Those contours were exported to the Tomotherapy planning station, were a trial nodal boost volume was drawn in. An IMRT plan was done for this volume, and the resultant Tomotherapy binary dose file was converted to a Pinnacle format in order to be integrated with the brachytherapy plan. Results: The megavoltage CT image accurately showed the source holders, tungsten shielding, and flange of the applicator. Exported doses distributions could be integrated with Tomotherapy IMRT. Conclusion: The Tomotherapy IMRT system will be useful to accurately image Fletcher‐Suit type applicators in actual patients in order to superimpose the dose distributions over the actual patient anatomy. IMRT delivered with Tomotherapy can easily be integrated with brachytherapy with the spread of DICOM dose export. Calculations which take the applicator shielding can be developed because the shielding position is clearly visible.
Title: SU‐FF‐T‐08: Tomotherapy Megavoltage Imaging for Gynecological Brachytherapy Treatment Planning and IMRT Integration
Description:
Purpose: To demonstrate the use of the Tomotherapy IMRT system to image the standard shielded Fletcher‐Suit applicator for CT based brachytherapy dose calculations and to integrate those dose distributions into Tomotherapy treatment plans.
Method and Materials: A standard Fletcher‐Suit gynecological applicator was placed in phantom and a megavoltage CT scan was done using the Tomotherapy unit.
The images were exported in DICOM format to a Pinnacle treatment planning system.
Cesium tubes representing a typical tandem and ovoid loading of the applicator were entered into the planning system, and the dose distribution was calculated.
The binary dose matrix was then converted to a CT‐like file by separating the dose values into individual planes, turning the floating point numbers into 12‐bit integers, and adding a header file.
Those image files was exported to a Focal Sim viewing station, where the isodose distribution was merged with a phantom CT and contours representing different isosurfaces were drawn.
Those contours were exported to the Tomotherapy planning station, were a trial nodal boost volume was drawn in.
An IMRT plan was done for this volume, and the resultant Tomotherapy binary dose file was converted to a Pinnacle format in order to be integrated with the brachytherapy plan.
Results: The megavoltage CT image accurately showed the source holders, tungsten shielding, and flange of the applicator.
Exported doses distributions could be integrated with Tomotherapy IMRT.
Conclusion: The Tomotherapy IMRT system will be useful to accurately image Fletcher‐Suit type applicators in actual patients in order to superimpose the dose distributions over the actual patient anatomy.
IMRT delivered with Tomotherapy can easily be integrated with brachytherapy with the spread of DICOM dose export.
Calculations which take the applicator shielding can be developed because the shielding position is clearly visible.

Related Results

Dosimetric comparison of 3DCRT and IMRT in radical chemoradiotherapy of squamous cell carcinoma esophagus
Dosimetric comparison of 3DCRT and IMRT in radical chemoradiotherapy of squamous cell carcinoma esophagus
ABSTRACT Background: Radical chemoradiation is the standard of treatment for locally advanced squamous cell carcinoma of esophagus and for patien...
Nasopharyngeal intracavitary brachytherapy
Nasopharyngeal intracavitary brachytherapy
AbstractBACKGROUNDLocally persistent nasopharyngeal carcinoma (NPC) carries an increased risk of local failure if additional treatment is not given. It has been shown that intracav...
Pain and Complications Assessment in Gynecological Cancer Brachytherapy Patients Under Spinal Anesthesia
Pain and Complications Assessment in Gynecological Cancer Brachytherapy Patients Under Spinal Anesthesia
Background: Brachytherapy is a radiation therapy that can deliver radiation to cancer by minimizing radiation exposure to adjacent organs or tissues. In its implementation, brachyt...
SU‐FF‐T‐458: Complementing Targeted Radionuclide Therapy with External Beam Radiotherapy: Planning Study
SU‐FF‐T‐458: Complementing Targeted Radionuclide Therapy with External Beam Radiotherapy: Planning Study
Purpose: Combining intensity modulated radiotherapy (IMRT) with targeted radionuclide therapy (TRT) can reduce local radiation toxicity. TRT systemically distributes the toxicity b...
Ten-Year Outcomes of IMRT With Chemotherapy Versus IMRT Alone for Stage Ⅱ-Ⅳa Nasopharyngeal Carcinoma: A Retrospective Study
Ten-Year Outcomes of IMRT With Chemotherapy Versus IMRT Alone for Stage Ⅱ-Ⅳa Nasopharyngeal Carcinoma: A Retrospective Study
Abstract Background Concurrent chemoradiotherapy (CCRT) is the cornerstone of treatment for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). However, ...
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
BACKGROUND: Infravesical obstruction in patients with localized prostate cancer caused by concomitant benign prostatic hyperplasia substantially limits the feasibility of low-dose-...

Back to Top